Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Antitrust Agencies Challenge Another Healthcare Provider Acquisition


August 9, 2012

Continuing a recent trend by antitrust enforcement authorities, on Monday the Federal Trade Commission ("FTC") and Nevada Attorney General announced proposed consent decrees settling litigation filed against Reno, Nevada's largest hospital provider, Renown Health, relating to its recent acquisitions of two cardiology physician groups. The announcement illustrates government agencies' renewed commitment to scrutinize healthcare transactions that might limit or eliminate competition among healthcare providers, seemingly regardless of size or reportability under the Hart-Scott-Rodino Act.

Renown Health operates general acute care hospitals and commercial health plans in the Reno area. Beginning in late 2010, Renown acquired one of two large cardiology groups in the Reno area consisting of 15 cardiologists. Less than a year later, Renown acquired the other cardiology group comprising another 17 doctors, allegedly resulting in Renown controlling 88% of Reno area cardiologists at the time of this litigation. The FTC called them the only significant cardiology groups in that area. In addition, Renown required the cardiologists to sign non-compete agreements to prevent them from leaving and joining competing practices. The antitrust enforcers claimed that the acquisitions and contracting practices effectively eliminated competition for adult cardiology services in that market.

Rather than seeking more traditional "structural remedies" such as requiring divestitures of the group practices or the sale of certain Renown assets, the FTC consent decree (and similar Nevada AG order) requires Renown to suspend its non-compete agreements for 30 days while the consent decree is open for public comment; during that time, the cardiologists are free to seek employment elsewhere. Up to 10 cardiologists can leave Renown without penalty. If the consent decree is approved by the FTC, the non-compete provisions will be suspended for an additional 30-day period. If 10 cardiologists have left at any time during this latter period, Renown can request reinstatement of its non-compete agreements. The suspensions will remain in place beyond the 30-day periods until at least six cardiologists have secured employment elsewhere. Among additional remedies, Renown must provide advance notice of future cardiology-related acquisitions and must reimburse investigation expenses incurred by taxpayers.

The Renown investigation, litigation and resolution is not the first of its kind. Other state attorneys general, including those in Maine and Pennsylvania, recently have challenged physician provider consolidations both prior to and after consummation that also ultimately resulted in conduct-based, rather than structural, remedies.

What's Next

Although larger hospital system mergers typically have garnered the most attention from government agencies, it is clear that there is a new commitment by the government to investigate and litigate any form of provider consolidation that could potentially harm competition in the provider market. Hospitals, health systems and other providers who are contemplating physician practice acquisitions, mergers or other forms of provider consolidation should fully consider the potential antitrust risks and consequences in evaluating these transactions.

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.